| Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021 | 91 | 2021 |
| Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short-and long-term clinical outcomes: a large, retrospective … M Stahl, RM Shallis, W Wei, P Montesinos, E Lengline, J Neukirchen, ... Leukemia 34 (12), 3149-3160, 2020 | 70 | 2020 |
| HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, AV Danilov, M Bower, ... Blood advances 5 (14), 2852-2862, 2021 | 36 | 2021 |
| Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics P Torka, SK Kothari, S Sundaram, S Li, LJ Medeiros, EC Ayers, ... Blood advances 4 (2), 253-262, 2020 | 34 | 2020 |
| Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study AS Zayac, AM Evens, A Danilov, SD Smith, D Jagadeesh, LA Leslie, ... Haematologica 106 (7), 1932, 2021 | 30 | 2021 |
| Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic … E Rabinovich, K Pradhan, RA Sica, L Bachier-Rodriguez, I Mantzaris, ... Experimental Hematology & Oncology 10 (1), 55, 2021 | 16 | 2021 |
| Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy RM Shallis, M Stahl, W Wei, P Montesinos, E Lengline, J Neukirchen, ... Leukemia & lymphoma 61 (5), 1220-1225, 2020 | 16 | 2020 |
| Outcomes of patients with newly-diagnosed Burkitt lymphoma (BL) and central nervous system (CNS) involvement treated in the modern era: A multi-institutional real-world analysis A Zayac, AM Evens, A Stadnik, SD Smith, D Jagadeesh, LA Leslie, C Wei, ... Blood 134, 402, 2019 | 14 | 2019 |
| Centralizing care of cancer-associated thromboembolism: The Cleveland Clinic experience E Rabinovich, JR Bartholomew, ML Wilks, BL Tripp, KR McCrae, ... Thrombosis research 147, 102-103, 2016 | 8 | 2016 |
| Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis CR D’angelo, W Hanel, Y Chen, M Yu, D Yang, L Guo, R Karmali, ... Hematological oncology 39 (4), 473-482, 2021 | 7 | 2021 |
| Refractory inflammatory myopathy in hematopoietic stem cell transplant patients with chronic graft-versus-host disease: report of two cases S Golec, E Rabinovich, M Cohen, L Baer, K Chamoun, M Lima Hematology, Transfusion and Cell Therapy 41, 268-271, 2019 | 6 | 2019 |
| A case of neurocognitive deficit strongly related to dasatinib therapy K Chamoun, E Rabinovich, L Baer, P Fastenau, M Lima Hematology, Transfusion and Cell Therapy 42, 80-82, 2020 | 5 | 2020 |
| The evaluation and treatment (Tx) of Burkitt lymphoma (BL) in the modern era: real world (RW) outcomes and prognostication across 26 US Cancer Centers (CC) AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood 134, 397, 2019 | 5 | 2019 |
| Characteristics, treatment patterns and outcomes among newly diagnosed patients (pts) with acute myeloid leukemia (AML) who present with hyperleukocytosis: findings from a … M Stahl, W Wei, P Montesinos, E Lengline, RM Shallis, J Neukirchen, ... Blood 132, 4040, 2018 | 5 | 2018 |
| Outcome of stem cell transplantation in HTLV-1-associated north American adult T-cell leukemia/lymphoma AH Bazarbachi, D Reef, H Narvel, R Patel, R Al Hamed, S Vikash, ... Clinical Hematology International 5 (2), 78-91, 2023 | 3 | 2023 |
| Outcomes of patients with limited-stage aggressive large B-cell lymphoma with MYC rearrangement with and without BCL2 and/or BCL6 rearrangements: a retrospective analysis from … SK Kothari, S Li, LJ Medeiros, EC Ayers, DJ Landsburg, DA Bond, ... Blood 132, 451, 2018 | 3 | 2018 |
| Prognostication, survival and treatment-related outcomes in HIV-associated Burkitt lymphoma (HIV-BL): a US and UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, A Danilov, M Bower, ... Blood 136, 49-50, 2020 | 2 | 2020 |
| Genomic strategies for personalized cancer therapy AZ Dudek, K Baxstrom, S Bharadwaj, A Blaes, A Kulkarni, E Lou, V Nehru, ... Precision Medicine in Oncology, 1-60, 2020 | 2 | 2020 |
| Improving outcomes and reducing costs for cancer associated thrombosis using a centralized service: the Cleveland clinic experience E Rabinovich, S Shrotriya, KR McCrae, JR Bartholomew, BJ Silver, ... Blood 126 (23), 1122, 2015 | 2 | 2015 |
| The Dual Inflammasome/Myddosome Inhibitor HT-6184 Restores Erythropoiesis in MDS/AML E Rabinovich, A Fromowitz, O Ajibade, S Sahu, D Verma, S Aminov, ... Blood 142, 1417, 2023 | 1 | 2023 |
